AI CAPITAL INTELLIGENCE
华深智药 · Multiple rounds · USD 787,000,000 · 2026-03-25
Financing facts, at a glance
华深智药: financing disclosed on 2026-03-25, Multiple rounds, USD 787,000,000. Named investors: Dimension Capital, DST Global, 高瓴资本, 渶策资本, Luminous Ventures, 琦迹资本, 赛诺菲, Biotech Development Fund. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
华深智药 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Multiple rounds, with an amount of USD 787,000,000. Named investors include Dimension Capital, DST Global, 高瓴资本, 渶策资本, Luminous Ventures, 琦迹资本, 赛诺菲, Biotech Development Fund.
- Disclosed company name
- 华深智药科技（北京）有限公司
- Disclosure date
- 2026-03-25
- Round
- Multiple rounds
- Financing amount
- USD 787,000,000
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Enterprise software
Disclosed investors
Dimension Capital, DST Global, 高瓴资本, 渶策资本, Luminous Ventures, 琦迹资本, 赛诺菲, Biotech Development Fund
Original sources
Record reviewed as of . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.